Search results
'Extraordinary' study results offer new hope for advanced lung cancer patients being treated with...
USA TODAY via Yahoo News· 2 years agoPatients with advanced lung cancer had a better chance at survival when their treatment combined...
Merck (MRK) Gets CHMP Nod for Keytruda in Adjuvant Lung Cancer
Zacks via Yahoo Finance· 9 months agoMerck's (MRK) Keytruda gets a positive CHMP opinion, recommending the approval of the drug for the...
First-Line Treatment for Lung Cancer
Verywell Health via Yahoo News· 2 years agoWhen you are diagnosed with lung cancer, the preferred initial treatment is called the first-line treatment. It may also be referred to as induction...
Merck's (MRK) Keytruda-Lynparza Combo Fails 2nd Lung Cancer Study
Zacks via Yahoo Finance· 3 months agoMerck's attempt to use the Keytruda-Lynparza combination in certain non-small cell lung cancer...
Merck's Keytruda gets FDA nod for expanded use in lung cancer
Reuters via Yahoo News· 8 months agoThe U.S. health regulator's approval extends Keytruda's use in combination with chemotherapy as a...
Advanced Lung Cancer and Immunotherapy
Verywell Health via Yahoo News· 9 months agoImmunotherapy is a newer class of treatment for lung and other cancers. It primes the body’s natural immune system to fight back against cancer....
Five-Year Data For Merck's Keytruda Plus Chemo Shows Sustained Survival Benefit In Lung Cancer...
Benzinga via Yahoo Finance· 2 years agoMerck & Co Inc (NYSE: MRK) Keytruda plus chemotherapy demonstrated a survival benefit and durable...
Merck's (MRK) Keytruda Early-Stage NSCLC Study Shows OS Benefit
Zacks via Yahoo Finance· 8 months agoMerck MRK announced that a pivotal phase III study evaluating its blockbuster PD-L1 inhibitor,...
Novocure Crashes 43% As Critics Question Its 'Profound' Impact In Lung Cancer Treatment
Investor's Business Daily· 1 year agoA medical device from Novocure extended overall survival for lung cancer patients, but NVCR stock...
BioNTech Surges On This Promising Update In Its Bid To Take On Bristol Myers In Lung Cancer...
Investor's Business Daily· 1 year agoGerman biotechnology company BioNTech said Friday almost a third of patients with a hard-to-treat...